Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Intensive Med ; 3(2): 171-184, 2023 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-37188113

RESUMEN

Background: Penehyclidine hydrochloride (PHC) has been used for many years as an anticholinergic drug for the treatment of acute organophosphorus pesticide poisoning (AOPP). The purpose of this meta-analysis was to explore whether PHC has advantages over atropine in the use of anticholinergic drugs in AOPP. Methods: We searched Scopus, Embase, Cochrane, PubMed, ProQuest, Ovid, Web of Science, China Science and Technology Journal Database (VIP), Duxiu, Chinese Biomedical literature (CBM), WanFang, and Chinese National Knowledge Infrastructure (CNKI), from inception to March 2022. After all qualified randomized controlled trials (RCTs) were included, we conducted quality evaluation, data extraction, and statistical analysis. Statistics using risk ratios (RR), weighted mean difference (WMD), and standard mean difference (SMD). Results: Our meta-analysis included 20,797 subjects from 240 studies across 242 different hospitals in China. Compared with the atropine group, the PHC group showed decreased mortality rate (RR=0.20, 95% confidence intervals [CI]: 0.16-0.25, P <0.001), hospitalization time (WMD=-3.89, 95% CI: -4.37 to -3.41, P <0.001), overall incidence rate of complications (RR=0.35, 95% CI: 0.28-0.43, P <0.001), overall incidence of adverse reactions (RR=0.19, 95% CI: 0.17-0.22, P <0.001), total symptom disappearance time (SMD=-2.13, 95% CI: -2.35 to -1.90, P <0.001), time for cholinesterase activity to return to normal value 50-60% (SMD=-1.87, 95% CI: -2.03 to -1.70, P <0.001), coma time (WMD=-5.57, 95% CI: -7.20 to -3.95, P <0.001), and mechanical ventilation time (WMD=-2.16, 95% CI: -2.79 to -1.53, P <0.001). Conclusion: PHC has several advantages over atropine as an anticholinergic drug in AOPP.

2.
Blood Purif ; 52(3): 296-308, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36450226

RESUMEN

BACKGROUND: Hemodialysis therapy has been used in the treatment of acute alcohol intoxication for many years, especially acute severe alcohol intoxication. OBJECTIVES: This study aimed to evaluate whether the combination of conventional treatment and naloxone with hemodialysis has advantages over conventional treatment and naloxone alone in patients with acute severe alcohol intoxication. METHODS: After searching 12 databases and 2 clinical trial centers. According to the established inclusion and exclusion criteria, the qualified literatures were screened. The outcome indicators were length of hospital stay, coma time, time of symptom disappearance, the overall complication rate, the incidence of pancreatitis, the incidence of aspiration pneumonia, the incidence of hepatic and renal dysfunction. Analysis was performed using Revman 5.3. RESULTS: This meta-analysis included 13 studies, including 932 subjects. In the treatment of acute severe alcohol intoxication, the use of hemodialysis on the basis of conventional treatment and naloxone could reduce the length of hospital stay (WMD = -15.16, 95% CI: -17.45 to -12.86, p < 0.001) in hours and (WMD = -4.89, 95% CI: -5.53 to -4.25, p < 0.001) in days; coma time (WMD = -5.43, 95% CI: -6.43 to -4.43, p < 0.001); time of symptom disappearance (WMD = -3.92, 95% CI: -5.37 to -2.47, p < 0.001); the overall complication rate (RR = 0.39, 95% CI: 0.28-0.55, p < 0.001); the incidence of pancreatitis (RR = 0.14, 95% CI: 0.05-0.43, p = 0.0006); the incidence of aspiration pneumonia (RR = 0.15, 95% CI: 0.04-0.66, p = 0.01), and the incidence of hepatic and renal dysfunction (RR = 0.21, 95% CI: 0.06-0.72, p = 0.01). CONCLUSIONS: It can be concluded that compared with the use of conventional treatment and naloxone alone, the use of hemodialysis on the basis of conventional treatment and naloxone for acute severe alcohol intoxication can reduce the length of hospital stay, coma time, time of symptom disappearance, and the incidence of some complications rate. Large scale, multicenter, and well-designed RCTs are needed in the future to prove our conclusions.


Asunto(s)
Intoxicación Alcohólica , Enfermedades Renales , Pancreatitis , Neumonía por Aspiración , Humanos , Intoxicación Alcohólica/terapia , Intoxicación Alcohólica/tratamiento farmacológico , Coma/terapia , Coma/tratamiento farmacológico , Pancreatitis/terapia , Diálisis Renal , Neumonía por Aspiración/tratamiento farmacológico , Naloxona/uso terapéutico , Enfermedades Renales/tratamiento farmacológico , Estudios Multicéntricos como Asunto
3.
Artículo en Inglés | MEDLINE | ID: mdl-36114994

RESUMEN

The present study aimed to examine how CRHBP rs10062367 polymorphism interacted with parenting styles and sensory processing sensitivity (SPS) to impact on preschoolers' internalizing problems. A total of 446 preschoolers (Mage = 4.55, SD = 1.07) participated in the study and their saliva were extracted to genotype the CRHBP rs10062367 polymorphism, and their parents were invited to complete a battery of questionnaires to assess parenting styles, preschoolers' SPS, and internalizing problems. Results indicated that high SPS preschoolers with A allele exhibited fewer internalizing problems under the condition of positive parenting while they exhibited more internalizing problems under the condition of negative parenting. The findings provide support for the Differential Susceptibility Model/Biological Sensitivity to Context Theory that A allele of rs10062367 and high SPS might be the "susceptibility markers" of children to environments.

4.
Front Behav Neurosci ; 13: 128, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31275121

RESUMEN

Background: As we human beings are living in a multidimensional space all the time. Therefore, spatial ability is vital for the survival and development of individuals. However, males and females show gender differences in this ability. So, are these gender differences influenced by the scale type of spatial ability? It's not well specified. Therefore, to tackle this issue, we conducted the current research from the behavioral and neural level. Methods: Study 1 used the general meta-analysis method to explore whether individuals display the same gender differences in large- and small-scale spatial ability. Study 2 used the method of Activation Likelihood Estimation to identify the commonalities and distinctions of the brain activity between males and females on large- and small-scale spatial ability. Results: Study 1 showed that in behavior performance, males outperformed females in both large-scale and small-scale spatial ability, but the effect size of the gender difference in large-scale spatial ability is significantly greater than that in small-scale spatial ability. In addition, Study 2 showed that in terms of neural activity, males and females exhibited both similarities and differences no matter in large-scale or small-scale spatial ability. Especially, the contrast analysis between females and males demonstrated a stronger activation in the brain regions of bilateral lentiform nucleus and bilateral parahippocampal gyrus in large-scale spatial ability, and correspondence in right sub-gyral, right precuneus, and left middle frontal gyrus in small-scale spatial ability. Conclusions: The results indicated that the reason why females performed not so well in large-scale spatial ability was that they were more susceptible to emotions and their parahippocampal gyrus worked less efficiently than males; females performed not so well in small-scale spatial ability because they mostly adopted the egocentric strategy and their sub-gyral also worked less efficiently than males. The two different reasons have made for gender differences in favor of males in terms of spatial ability and such gender differences have different manifestations in large-scale and small-scale spatial ability. Possible implications of the results for understanding the issue of gender differences in spatial ability are discussed.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...